Stock AGL AGILON HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News agilon health, inc.

Equities

AGL

US00857U1079

Market Closed - Nyse
Other stock markets
 01:30:03 01/06/2024 am IST 		5-day change 1st Jan Change
6.3 USD +0.96% Intraday chart for agilon health, inc. +3.45% -49.80%
30/05 Baird Starts agilon health With Neutral Rating, $6 Price Target MT
24/05 Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Baird Starts agilon health With Neutral Rating, $6 Price Target
MT
Agilon health to Participate at 44th Annual William Blair Growth Stock Conference
BU
Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating
MT
Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (AGL)
PR
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
PR
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit
PR
Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGL
PR
May 20, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AGL
PR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in agilon health Lawsuit - AGL
PR
Investors who lost money on agilon health, inc.(AGL) should contact Levi & Korsinsky about pending Class Action - AGL
PR
AGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon health, inc. - AGL
PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
PR
Kessler Topaz Meltzer & Check, LLP Reminds agilon health, inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit (AGL)
PR
Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating
MT
Agilon health, inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL
PR
Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024
Agilon: Q1 Earnings Snapshot
AQ
Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, vs. Street Est of $1.61B
MT
Agilon health Reports First Quarter 2024 Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGL Stock
  4. News agilon health, inc.